RGEN Relative Valuation
RGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RGEN is overvalued; if below, it's undervalued.
Historical Valuation
Repligen Corp (RGEN) is now in the Fair zone, suggesting that its current forward PE ratio of 77.17 is considered Fairly compared with the five-year average of 84.52. The fair price of Repligen Corp (RGEN) is between 124.88 to 189.09 according to relative valuation methord.
Relative Value
Fair Zone
124.88-189.09
Current Price：152.07
Fair
77.17
PE
1Y
3Y
5Y
Trailing
Forward
54.54
EV/EBITDA
Repligen Corp. (RGEN) has a current EV/EBITDA of 54.54. The 5-year average EV/EBITDA is 56.99. The thresholds are as follows: Strongly Undervalued below 27.53, Undervalued between 27.53 and 42.26, Fairly Valued between 71.72 and 42.26, Overvalued between 71.72 and 86.45, and Strongly Overvalued above 86.45. The current Forward EV/EBITDA of 54.54 falls within the Historic Trend Line -Fairly Valued range.
73.04
EV/EBIT
Repligen Corp. (RGEN) has a current EV/EBIT of 73.04. The 5-year average EV/EBIT is 71.59. The thresholds are as follows: Strongly Undervalued below 25.90, Undervalued between 25.90 and 48.75, Fairly Valued between 94.44 and 48.75, Overvalued between 94.44 and 117.28, and Strongly Overvalued above 117.28. The current Forward EV/EBIT of 73.04 falls within the Historic Trend Line -Fairly Valued range.
149.00
PS
Repligen Corp. (RGEN) has a current PS of 149.00. The 5-year average PS is 15.65. The thresholds are as follows: Strongly Undervalued below -12.74, Undervalued between -12.74 and 1.45, Fairly Valued between 29.85 and 1.45, Overvalued between 29.85 and 44.04, and Strongly Overvalued above 44.04. The current Forward PS of 149.00 falls within the Strongly Overvalued range.
58.53
P/OCF
Repligen Corp. (RGEN) has a current P/OCF of 58.53. The 5-year average P/OCF is 61.70. The thresholds are as follows: Strongly Undervalued below 32.25, Undervalued between 32.25 and 46.98, Fairly Valued between 76.43 and 46.98, Overvalued between 76.43 and 91.16, and Strongly Overvalued above 91.16. The current Forward P/OCF of 58.53 falls within the Historic Trend Line -Fairly Valued range.
70.16
P/FCF
Repligen Corp. (RGEN) has a current P/FCF of 70.16. The 5-year average P/FCF is 101.75. The thresholds are as follows: Strongly Undervalued below 33.81, Undervalued between 33.81 and 67.78, Fairly Valued between 135.72 and 67.78, Overvalued between 135.72 and 169.69, and Strongly Overvalued above 169.69. The current Forward P/FCF of 70.16 falls within the Historic Trend Line -Fairly Valued range.
Repligen Corp (RGEN) has a current Price-to-Book (P/B) ratio of 4.03. Compared to its 3-year average P/B ratio of 4.36 , the current P/B ratio is approximately -7.66% higher. Relative to its 5-year average P/B ratio of 5.44, the current P/B ratio is about -26.05% higher. Repligen Corp (RGEN) has a Forward Free Cash Flow (FCF) yield of approximately 0.01%. Compared to its 3-year average FCF yield of 1.24%, the current FCF yield is approximately -98.94% lower. Relative to its 5-year average FCF yield of 0.90% , the current FCF yield is about -98.54% lower.
4.03
P/B
Median3y
4.36
Median5y
5.44
0.01
FCF Yield
Median3y
1.24
Median5y
0.90
Competitors Valuation Multiple
The average P/S ratio for RGEN's competitors is 114.11, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN) exhibits a P/S ratio of 149.00, which is 30.58% above the industry average. Given its robust revenue growth of 21.91%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of RGEN decreased by 1.02% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 284.52 to 5.86K.
The secondary factor is the Revenue Growth, contributed 21.91%to the performance.
Overall, the performance of RGEN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Repligen Corp (RGEN) currently overvalued or undervalued?
What is Repligen Corp (RGEN) fair value?
How does RGEN's valuation metrics compare to the industry average?
What is the current P/B ratio for Repligen Corp (RGEN) as of Nov 19 2025?
What is the current FCF Yield for Repligen Corp (RGEN) as of Nov 19 2025?
What is the current Forward P/E ratio for Repligen Corp (RGEN) as of Nov 19 2025?